KF
GH icon

Krilogy Financial’s Guardant Health GH Stock Holding History

Krilogy Financial’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.78M Buy
+32,436
New +$3.26M 0.09% 182

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Krilogy Financial's GH Position: Q1 2026 in Review

Krilogy Financial opened a new position in Guardant Health (GH) in Q1 2026: 32,436 shares worth $2.78M. The stake represents 0.09% of the portfolio and ranks #182 among its holdings.

481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Krilogy Financial held 32,436 shares of Guardant Health worth $2.78M as of Q1 2026.
  • Guardant Health was a new Krilogy Financial position in Q1 2026.
  • Guardant Health made up 0.09% of Krilogy Financial's portfolio in Q1 2026, its #182 holding.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Krilogy Financial's 13F filing for Q1 2026, filed 17 Apr 2026.